Regular readers will probably know me as the one who got really into turntables recently; overhauling my home system (twice!) to make it vinyl-focused and running our annual Vinyl Week celebrations ...

Private equity investor Arcus Infrastructure Partners has bought a majority stake in regional aircraft lessor TrueNoord, its only current investment in the aviation sector. Arcus agreed to buy a 74% ...

The Mega Millions jackpot is climbing again ahead of the Tuesday, April 28 drawing, reaching $163 million, with a cash option of $72.9 million. If there’s a jackpot winner on April 28, they’ll choose ...

Arcus Biosciences (RCUS) traded lower in the premarket on Monday after the oncology-focused biotech announced the discontinuation of a late-stage trial designed to evaluate its anti-TIGIT therapy ...

Arcus Biosciences is discontinuing a phase 3 lung cancer trial it was conducting with Gilead Sciences. Arcus, an oncology company, said Monday it was ending the trial due to futility, meaning it doesn ...

Hello, everyone, and thank you for joining the Arcus Biosciences Full Year and Fourth Quarter 2025 Earnings and Financial Results Call. My name is Claire and I'll be coordinating your call today.

Pokémon Go has updated Mega Evolution and Mega Raids, introducing Super Mega Raids. While yes, it's a silly name and the changes seem daunting, it's not actually that different. The main thing is that ...

As Pokémon Go announces a seismic shakeup of its Mega Pokémon, IGN has chatted with the smash hit smartphone game's developer on the inspirations for the move, what's changing for the better, and what ...

You can open a certificate of deposit (CD) with the best of intentions. The thinking at the time is that you will leave your money untouched for a certain time period, and earn a steady predictable ...

Arcus Infrastructure Partners will acquire Wifinity, a UK-based internet managed services provider, from LDC and Literacy Capital. Literacy will generate a total expected return of 5.2x MoM, in line ...

Dec 12 (Reuters) - Arcus Biosciences (RCUS.N), opens new tab said on Friday it would stop a late-stage study testing its experimental cancer drug combination in patients with advanced stomach and ...

A key late-stage trial of Arcus Biosciences and Gilead Sciences' anti-TIGIT antibody domvanalimab has flopped, leading Arcus to refocus its R&D priorities and abandon several studies of the drug. The ...